DP

Diadema Partners Portfolio holdings

AUM $144M
1-Year Est. Return 22.15%
This Quarter Est. Return
1 Year Est. Return
+22.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$144M
AUM Growth
-$17.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
128
New
Increased
Reduced
Closed

Top Buys

1 +$13.8M
2 +$6.13M
3 +$5.86M
4
ASND icon
Ascendis Pharma
ASND
+$5.48M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.56M

Top Sells

1 +$14.5M
2 +$11.5M
3 +$11.2M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$10.7M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$7.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$77.1B
$17M 4.34%
30,160
+24,553
SLNO icon
2
Soleno Therapeutics
SLNO
$2.71B
$12M 3.07%
177,330
-106,822
BMRN icon
3
BioMarin Pharmaceuticals
BMRN
$10.3B
$11.5M 2.95%
212,877
+20,000
PCVX icon
4
Vaxcyte
PCVX
$6.05B
$7.86M 2.01%
218,285
+20,000
INDV icon
5
Indivior
INDV
$4.3B
$6.13M 1.57%
+254,252
BMY icon
6
Bristol-Myers Squibb
BMY
$103B
$5.86M 1.5%
+130,000
ASND icon
7
Ascendis Pharma
ASND
$12.4B
$5.48M 1.4%
+27,572
NBIX icon
8
Neurocrine Biosciences
NBIX
$15.2B
$5.3M 1.36%
37,754
-56,288
VKTX icon
9
Viking Therapeutics
VKTX
$4.02B
$5.09M 1.3%
193,689
-3,779
ALNY icon
10
Alnylam Pharmaceuticals
ALNY
$63B
$4.56M 1.17%
+10,000
IMCR icon
11
Immunocore
IMCR
$1.9B
$4.52M 1.16%
124,384
+20,000
NKTR icon
12
Nektar Therapeutics
NKTR
$1.13B
$4.27M 1.09%
+75,000
ABVX
13
Abivax
ABVX
$8.75B
$3.51M 0.9%
+41,620
PTGX icon
14
Protagonist Therapeutics
PTGX
$5.37B
$3.4M 0.87%
51,185
-25,000
JAZZ icon
15
Jazz Pharmaceuticals
JAZZ
$10.2B
$3.05M 0.78%
23,140
-81,333
ANIP icon
16
ANI Pharmaceuticals
ANIP
$1.86B
$2.88M 0.74%
+31,400
RVMD icon
17
Revolution Medicines
RVMD
$14.9B
$2.76M 0.71%
59,079
-20,000
APGE icon
18
Apogee Therapeutics
APGE
$5.01B
$2.55M 0.65%
64,250
+53,678
TERN icon
19
Terns Pharmaceuticals
TERN
$2.44B
$2.43M 0.62%
323,159
+63,307
ARDX icon
20
Ardelyx
ARDX
$1.39B
$2.2M 0.56%
+400,000
TGTX icon
21
TG Therapeutics
TGTX
$5B
$2.19M 0.56%
60,748
-310,700
ALKS icon
22
Alkermes
ALKS
$4.93B
$2.16M 0.55%
+72,079
ROIV icon
23
Roivant Sciences
ROIV
$14.4B
$1.82M 0.46%
+120,000
URGN icon
24
UroGen Pharma
URGN
$1.18B
$1.8M 0.46%
90,000
-60,000
PCRX icon
25
Pacira BioSciences
PCRX
$1.04B
$1.52M 0.39%
58,926